Evidence map›Paper›PMID 32326955›Full record

Observational studyItalian journal of pediatrics2020

A caregiver-reported global severity assessment in pediatric atopic eczema: the Comano score.

Mattia Giovannini, Davide Geat, Gabriele Barlocco, Riccardo Pertile, Francesca Mori, Cesare Filippeschi, Elio Novembre, Mario Cristofolini, Ermanno Baldo

Open access · goldAbstract readLetterObservational Study
In one paragraph

Observational study in Italian journal of pediatrics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Observational
  4. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Mattia GiovanniniAllergy Unit, Department of Pediatrics, Anna Meyer Children's University Hospital, Florence, Italy.
Davide GeatPost-Graduate School of Dermatology, Section of Dermatology and Venerology, Department of Medicine, University of Verona, Verona, Italy.
Gabriele Barlocco"Giovan Battista Mattei" Research Institute, Stenico, Italy.
Riccardo PertileDepartment of Clinical and Evaluative Epidemiology, Trento Health Service, Trento, Italy.
Francesca MoriAllergy Unit, Department of Pediatrics, Anna Meyer Children's University Hospital, Florence, Italy.
Cesare FilippeschiDermatology Unit, Department of Pediatrics, Anna Meyer Children's University Hospital, Florence, Italy.
Elio NovembreAllergy Unit, Department of Pediatrics, Anna Meyer Children's University Hospital, Florence, Italy.
Mario Cristofolini"Giovan Battista Mattei" Research Institute, Stenico, Italy.
Ermanno Baldo"Giovan Battista Mattei" Research Institute, Stenico, Italy. ermanno@baldo.tn.it.
Meyer Children's Hospital · ITAzienda Ospedaliero Universitaria San Giovanni Battista · ITProvincia Autonoma di Trento · ITUniversity of Verona · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atopic eczema (AE) is the most common inflammatory skin disease in infancy and its prevalence is rising worldwide. It has a wide social impact on the affected children and their families' lives. AE can have a chronic and heterogeneous course, with periods of remission and relapse of the clinical manifestations. For this reason, its severity assessment through standardized outcome measures becomes a fundamental guide for health professionals, who can manage AE following evidence-based medicine principles in their everyday clinical practice or in clinical trials.Several scoring systems have been recognized to assess the clinical manifestations of AE, both from the physician's and the patient's point of view. Despite the scoring systems standardized for adults, there are very few published options about the expression of a patient/caregiver-centered global severity assessment specifically for pediatric AE. For this reason, the aim of our study was to evaluate a new, quick, user-friendly and feasible caregiver-reported global severity assessment for pediatric AE. Based on a 0-10 numerical rating scale in pediatric AE, we named this scoring system the Comano score.We carried out a cross-sectional observational study enrolling a total of 867 patients aged from 1 to 16 years (males 49.5%, mean patient's age 5.9 years, standard deviation ±3.6 years) with a previous doctor-confirmed diagnosis of AE, who underwent balneotherapy at Comano Thermal Center (Comano, Trentino, Italy). A strong correlation between Comano score and SCORing Atopic Dermatitis (SCORAD) was observed (r = 0.74, p < 0.0001).According to our results, the Comano score may be a promising new tool for the expression of a caregiver-reported global severity assessment in pediatric AE. However, further data are needed to confirm our preliminary findings before health professionals can use this scoring system in their everyday clinical practice to manage pediatric AE. Still, as a patient-focused measure, the Comano score may facilitate delivering person-centered care so as to define a measure for a clinical impact that can be meaningful to the subject, which is gaining importance in modern medicine.

Indexed as

CaregiversAdolescentChildChild, PreschoolCross-Sectional StudiesDermatitis, AtopicFemaleHumansInfantItalyMaleSeverity of Illness IndexAtopic dermatitisChildren, Person-centered careComano scoreScoring system

Identifiers

PMID32326955
PMCPMC7181490
OpenAlexW3018921800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.